President Biden intends to appoint six members to the National Cancer Advisory Board.
The NCI Board of Scientific Advisors unanimously approved six new concepts and two reissue concepts at a joint meeting of the BSA and the National Cancer Advisory Board.
NCI is moving forward with a plan to evaluate multi-cancer early detection tests, a technology that is rapidly making inroads into the healthcare system.
The NCI Board of Scientific Advisors unanimously approved eight new concepts and nine reissued concepts at a meeting June 13-15.
President Joe Biden’s new national goal for the reignited Cancer Moonshot—to cut today’s age-adjusted cancer mortality rates by at least 50% before 2050—is bold, but achievable, said NCI Director Ned Sharpless.
NCI is temporarily reducing its paylines as the federal government is being funded at FY2021 levels via another continuing resolution, delaying the budgeting process for most federal agencies in the new fiscal year.
On Dec. 8, 2020, a month after losing the election, then-president Donald Trump announced his intent to name 26 people to advisory boards across the federal government. Among them were three would-be members of the National Cancer Advisory Board, and in the months following, these three appointments—which have been blocked and ultimately terminated by the... […]
NCI is asking for an appropriation of $7.8 billion for fiscal year 2023—about $800 million above the House’s FY22 proposed budget for NCI.
A recent analysis of the National Cancer Institute’s workforce and grant recipients shows that Black and Hispanic scientists are dramatically underrepresented across key metrics, both intramural and extramural.
